Abstract
Chronic lymphocytic leukemia (CLL) is a low-grade lymphoid malignancy incurable with conventional modalities of chemotherapy. We aimed to examine the proapoptotic effects of a novel proteasome inhibitor, N,N'-di-(m-methylphenyi)-3,6- dimethyl-1,4-dihydro-1,2,4,5-tetrazine-1,4-dicarboamide (ZGDHu-1), on CLL cells. B lymphocytes were isolated from CLL patients and normal healthy controls, and treated with various concentrations of ZGDHu-1 for different days. CLL cell viability was detected by MTT assay. The apoptosis, mitochondrial membrane potential (∆ψm) and reactive oxidative species (ROS) were examined by flow cytometry. The expression of caspase-3 and Bcl-2/Bax ratio was detected by western blotting. ZGDHu-1 significantly reduced the viability of CLL cells and induced apoptosis in comparison to the control cells (both P<0.05). Normal peripheral B cells were resistant to the apoptosis-inducing effects of ZGDHu-1. Apoptosis induced by ZGDHu-1 was accompanied with generation of ROS, loss of ∆ψm, downregulation of Bcl-2 and increase of caspase-3 cleavage. Results of this study indicate that ZGDHu-1 is a promising specific treatment for CLL in the clinic.
References
Jun 1, 1989·British Journal of Haematology·D CatovskyS Richards
Nov 1, 1995·The Journal of Experimental Medicine·S J MartinD R Green
Jul 6, 1995·Nature·D W NicholsonY A Lazebnik
Mar 10, 1995·Science·C B Thompson
Jan 1, 1994·Analytical Biochemistry·F K ShakirK M Shakir
Jan 1, 1994·The Journal of Cell Biology·J C Reed
Oct 28, 1996·FEBS Letters·P X PetitG Kroemer
Jun 19, 1997·Nature·J C Reed
May 23, 1998·Annual Review of Immunology·D T Chao, S J Korsmeyer
Sep 12, 1998·Science·J M Adams, S Cory
Jan 23, 1999·Oncogene·J C Reed
Mar 21, 2001·Apoptosis : an International Journal on Programmed Cell Death·H U SimonF Levi-Schaffer
Aug 23, 2001·Leukemia·J B AlmondG M Cohen
Apr 24, 2002·Oncogene·Ryouichi HorieToshiki Watanabe
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Feb 8, 2003·British Journal of Biomedical Science·Andrew P Jewell
May 27, 2003·Apoptosis : an International Journal on Programmed Cell Death·J D LyA Lawen
Jun 4, 2004·Leukemia·S CuníA Durántez
Apr 9, 2005·European Journal of Haematology·Markus DuechlerPiotr Smolewski
Apr 25, 2006·Leukemia Research·Piotr SmolewskiTadeusz Robak
May 20, 2006·Bioorganic & Medicinal Chemistry Letters·Guo-Wu Rao, Wei-Xiao Hu
Jul 13, 2006·Cancer·Stefan FaderlMichael J Keating
May 26, 2007·Leukemia·S InoueG M Cohen
Dec 28, 2007·Blood·Feng-Ting LiuLi Jia
Jun 26, 2008·Blood·Laura Z RassentiThomas J Kipps
Nov 15, 2008·Blood·Meike VoglerGerald M Cohen
Jan 5, 2010·Apoptosis : an International Journal on Programmed Cell Death·Tibor Kiss
Feb 4, 2010·Viral Immunology·Xue-Ping NanXue-Fan Bai
Jan 29, 2011·World Journal of Gastroenterology : WJG·Bao-Song ZhuZheng-Hong Qin
Citations
Sep 30, 2015·Redox Biology·Ahmad SalimiJalal Pourahmad
Dec 31, 2016·Oncotarget·Liannv QiuYonglie Zhou
Jan 19, 2018·Oncology Letters·Jinlin LiuYonglie Zhou
Jan 13, 2015·International Journal of Oncology·Małgorzata RogalińskaZofia M Kiliańska
Jul 15, 2015·Oncology Reports·Liannv QiuYonglie Zhou
Jul 23, 2016·Oncology Letters·Xinfeng ShenYonglie Zhou
Apr 24, 2018·Oxidative Medicine and Cellular Longevity·Subir Roy Chowdhury, Versha Banerji
Nov 1, 2016·Nutrition and Cancer·Ahmad SalimiJalal Pourahmad